Limits to Height

In 1961, Leonard Hayflick and Paul Moorhead demonstrated that normal human somatic cells possess a finite proliferative lifespan, which is governed not by chronological time but by the cumulative number of cell divisions. To protect critical genetic material from eroding, eukaryotic cells cap the ends of their DNA with noncoding, repetitive sequences known as telomeres. In germ cells and early embryonic stem cells, high levels of the specialized enzyme telomerase preserve telomere length. However, in human somatic cells, lower telomerase activity fails to prevent progressive telomere shortening, imposing a strict limit on their proliferative capacity.

Taller bodies consist of considerably more cells than smaller bodies, and thus require a higher volume of continuous cell replications to replace damaged or old cells. According to the Hayflick Limit, most somatic cells have a limit of up to 40 to 60 possible divisions. Consequently, larger bodies are likely to exhaust their replication capacities sooner than small bodies and have a lower average life expectancy. This aligns with data showing a correlation between large body size and age-associated malignancies, such as cardiovascular disease, severe type 2 diabetes, impaired wound healing, immunosenescence, and cancer.

Conversely, the secular increase in height in the Western world over the past 150 years (where each generation has increased by roughly 2.5 cm) has traditionally been celebrated as a sign of improved childhood nutrition and public health. However, this ongoing increase in human size presents a clear biological trade-off. Ultimately, lower mortality rates, especially in old age, are heavily supported by the cellular reality that over a lifetime a smaller body places significantly less replicative demand on its adult stem cells. Perhaps the largest gains in public health are to be found in reversing our obsession with increasing height.